Globe Life Inc. (NYSE:GL – Get Free Report) CFO Thomas Peter Kalmbach sold 11,903 shares of the stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $156.61, for a total value of $1,864,128.83. Following the sale, the chief financial officer owned 48,432 shares in the company, valued at approximately $7,584,935.52. This represents a 19.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Thomas Peter Kalmbach also recently made the following trade(s):
- On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The shares were sold at an average price of $152.02, for a total value of $1,792,315.80.
- On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The shares were sold at an average price of $153.65, for a total value of $2,402,625.05.
Globe Life Stock Performance
GL stock opened at $156.46 on Friday. The company has a market cap of $12.15 billion, a P/E ratio of 10.82 and a beta of 0.50. Globe Life Inc. has a 1 year low of $116.73 and a 1 year high of $157.92. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. The stock’s fifty day moving average price is $147.24 and its 200-day moving average price is $141.91.
Globe Life Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is 9.13%.
Wall Street Analyst Weigh In
GL has been the topic of a number of research reports. Weiss Ratings upgraded Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, May 13th. Keefe, Bruyette & Woods restated a “moderate buy” rating and issued a $168.00 price target on shares of Globe Life in a research note on Thursday, March 26th. JPMorgan Chase & Co. raised their price target on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Evercore set a $157.00 price target on Globe Life in a research note on Wednesday, February 18th. Finally, Piper Sandler upgraded Globe Life to a “strong-buy” rating in a research note on Thursday, April 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, Globe Life presently has a consensus rating of “Buy” and a consensus price target of $173.22.
Check Out Our Latest Report on Globe Life
Hedge Funds Weigh In On Globe Life
Several institutional investors and hedge funds have recently bought and sold shares of GL. Groupama Asset Managment bought a new stake in Globe Life during the first quarter valued at about $466,000. Edgestream Partners L.P. bought a new stake in Globe Life during the first quarter valued at about $7,513,000. Bull Harbor Capital LLC bought a new stake in Globe Life during the first quarter valued at about $538,000. Amundi raised its holdings in Globe Life by 627.5% during the first quarter. Amundi now owns 39,821 shares of the company’s stock valued at $5,542,000 after acquiring an additional 34,347 shares during the period. Finally, EverSource Wealth Advisors LLC raised its holdings in Globe Life by 4.0% during the first quarter. EverSource Wealth Advisors LLC now owns 2,366 shares of the company’s stock valued at $329,000 after acquiring an additional 91 shares during the period. 81.61% of the stock is currently owned by hedge funds and other institutional investors.
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Featured Stories
- Five stocks we like better than Globe Life
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
